What's Cooking?....., page-5

howdy everyone, my logic behind my "whats cooking" header is that there simply has to be....
from the Edison report...
We note that our valuation includes a modest allowance for new indications for efti beyond the ongoing studies in melanoma, lung and head and neck cancers.

OK, the word "modest"implies conservative to me, I take that to mean there is activity in the research dept and Edison like
what they see but don't want to overstate it at this point in time.

To explain my thoughts, Immutep can only sell something once.....Say we licence out AIPAC and Tacti-mel 1 and 2 what
have we got left?......INSIGHT and not much more than existing partnerships....

There has to be a forward looking business plan with objectives for expansion  of the research dept...

I still think there is more to the appointment of Mathieu Arnaud?, HIV research scientist, to our
laboratory....time will tell with that though.....

Just my thoughts on paper but make your own mind up, have a great weekend....